Page last updated: 2024-09-04

edotreotide and etoposide

edotreotide has been researched along with etoposide in 1 studies

Compound Research Comparison

Studies
(edotreotide)
Trials
(edotreotide)
Recent Studies (post-2010)
(edotreotide)
Studies
(etoposide)
Trials
(etoposide)
Recent Studies (post-2010) (etoposide)
206348618,3063,6934,900

Protein Interaction Comparison

ProteinTaxonomyedotreotide (IC50)etoposide (IC50)
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]Homo sapiens (human)1.153
nuclear receptor coactivator 3 isoform aHomo sapiens (human)1.4284
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)3.187
Caspase-3Homo sapiens (human)1
DNA topoisomerase 2-betaHomo sapiens (human)0.4299
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)4.18

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Essler, M; Krause, BJ; Maurer, T; Souvatzoglou, M; Treiber, U; Weirich, G1

Other Studies

1 other study(ies) available for edotreotide and etoposide

ArticleYear
68Ga-DOTATOC-PET/CT detects neuroendocrine differentiation of prostate cancer metastases.
    Nuklearmedizin. Nuclear medicine, 2009, Volume: 48, Issue:5

    Topics: Anilides; Antineoplastic Agents; Cell Differentiation; Cisplatin; Etoposide; Humans; Male; Middle Aged; Nitriles; Octreotide; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed; Tosyl Compounds

2009